Email
Password
Remember meForgot password?
    Log in with Twitter

article imageHIV-1 may be weakened by THC to enhance antiviral therapies

By Owen Weldon     May 2, 2013 in Health
New research reveals that it is possible that compounds that stimulate the cannabinoid type 2 (CB2) receptor in white blood cells can make the HIV-1 infection weaker.
According to Eurekalert, the CB2 receptor is the molecular link through which cannabis's properties are manifested. Current anti-viral therapies could be more effective when the HIV-1 infection is diminished in this way.
According to Medical Daily, the way the process works is by interaction with the CB2 receptor, specifically the macrophages, which is a type of white blood cell in people. Macrophages work by surrounding damaged cells and then engulfing them, while at the same time alerting lymphocytes when there are new dangers.
According to Wired, synthetic versions of THC, have been developed but only for research purposes, and further research is needed.
The study can be found here.
More about HIV, Hiv1, Infection, Thc
 
Latest News
Top News